A Food and Drug Administration panel on Wednesday advocated for regulatory changes that would make testosterone medications more widely accessible, including removing their classification as ...

Oscilloscope Laboratories has acquired “John Lilly and the Earth Coincidence Control Office,” a documentary about a daring neurophysiologist and “psychonaut” known for his investigations into dolphins ...

Mounjaro's consumption in India by volume was 10 times more than Wegovy in October, the firm said. Eli Lilly's blockbuster obesity drug Mounjaro became India's top-selling drug by value for the month ...

If approved, EBGLYSS would be a first-line biologic that offers the option of monotherapy with once every eight-week maintenance dosing in moderate-to-severe atopic dermatitis uncontrolled by topicals ...

Eli Lilly has signed a distribution and promotion agreement with Cipla to expand access to its blockbuster diabetes and obesity drug tirzepatide in India, marking the first such deal by the US pharma ...

Oct 15 (Reuters) - Eli Lilly's (LLY.N), opens new tab experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage trials, the company said on Wednesday ...

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5, orforglipron lowered A1C by an additional 2.1% when taken with ...